about
Preparation and characterization of the 'research chemical' diphenidine, its pyrrolidine analogue, and their 2,2-diphenylethyl isomers.Test purchase, synthesis, and characterization of 2-methoxydiphenidine (MXP) and differentiation from its meta- and para-substituted isomers.Test purchase, synthesis and characterization of 3-fluorophenmetrazine (3-FPM) and differentiation from its ortho- and para-substituted isomers.Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N-methoxy positional isomer, N-methoxymephedrone.Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3',4'-methylenedioxy-4-methylaminorex (MDMAR).Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo and (±)-erythro diastereomers.Identification and characterization of an imidazolium by-product formed during the synthesis of 4-methylmethcathinone (mephedrone).In vitro metabolism of the synthetic cannabinoid 3,5-AB-CHMFUPPYCA and its 5,3-regioisomer and investigation of their thermal stability.'APAAN in the neck' - A reflection on some novel impurities found in seized materials containing amphetamine in Ireland during routine forensic analysis.Outsmarted by nootropics? An investigation into the thermal degradation of modafinil, modafinic acid, adrafinil, CRL-40,940 and CRL-40,941 in the GC injector: formation of 1,1,2,2-tetraphenylethane and its tetra fluoro analog.Forensic analysis of P2P derived amphetamine synthesis impurities: identification and characterization of indene by-products.Synthesis, analytical characterization and monoamine transporter activity of the new psychoactive substance 4-methylphenmetrazine (4-MPM), with differentiation from its ortho- and meta- positional isomers.The synthesis and characterization of the 'research chemical' N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide (3,5-AB-CHMFUPPYCA) and differentiation from its 5,3-regioisomer.
P50
Q34430008-444E797D-A4CB-4036-A189-E97736DB35C9Q34471630-E8DEDBC4-ED8F-4EF5-BED8-753AD26510F0Q34510784-D4AC748F-CC3D-403F-A152-356B30C90769Q34537347-33B88B19-6737-4D0A-BBA4-66A3F82C43B6Q37673496-D287AD40-47A9-4BDA-BA10-F688825CF5BCQ37735980-953A79BB-0263-4A78-9A47-7EE6D5884E3DQ41109306-F8A6249F-F20A-4CBB-8C3F-92D76998F135Q46594306-D4AD5CBD-BDE8-4C77-8F28-873593A7DAA6Q48088901-58396E16-458E-4E3B-9C49-2237FB6E32F5Q50213399-BD08E720-EA90-48E6-A40A-19BEFF9A3D4FQ50235188-8BCB340B-E730-41CE-83E0-D0D31ADF58ADQ52577544-D6AA5B6A-4F6F-4895-98E1-170EB02514E2Q53354509-8DAC32E0-1208-4E2F-A234-CA56080077B0
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gavin McLaughlin
@ast
Gavin McLaughlin
@en
Gavin McLaughlin
@es
Gavin McLaughlin
@sl
type
label
Gavin McLaughlin
@ast
Gavin McLaughlin
@en
Gavin McLaughlin
@es
Gavin McLaughlin
@sl
prefLabel
Gavin McLaughlin
@ast
Gavin McLaughlin
@en
Gavin McLaughlin
@es
Gavin McLaughlin
@sl
P106
P21
P31
P496
0000-0002-2496-8396